Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Positron Emission Tomography: early-phase trial registry

1 of 2 indexed Positron Emission Tomography trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Positron Emission Tomography: 2 US clinical trials tracked, 1 recruiting.

Positron Emission Tomography is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Davis, running 2 of these trials.

Enrollment posture brief

Registry condition positron-emission-tomography

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Positron Emission Tomogr (th…50%
Open-enrollment share among volume-matched conditions near Positron Emission Tomography

Positron Emission Tomography lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Positron Emission Tomography on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Positron Emission Tomography is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Positron Emission Tomography records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

mCT/uEXPLORER Device
1 trials
uEXPLORER/mCT Device
1 trials
18F-FDG Drug
1 trials
18F-DPA-714 Drug
1 trials

US sites by state

Facility locations filed on Positron Emission Tomography trials. A trial with sites in several states counts in each.

California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Positron Emission Tomography page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Positron Emission Tomography condition card totals 2 registered trials; most-linked intervention mCT/uEXPLORER; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.